Updated Today
If the FDA approves COMP360 Psilocybin for Treatment-Resistant Depression for marketing before Jan 1, 2028, then the market resolves to Yes.
As of March 28, 2026, the Kalshi odds for When will the FDA approve COMP360 Psilocybin for Treatment-Resistant Depression? are: Before 2028: 55%, Before October 2027: 35%, Before July 2027: 10%. These probabilities are derived from real-money trading and update in real time.
When will the FDA approve COMP360 Psilocybin for Treatment-Resistant Depression? is currently available on Kalshi. Check PredictMarketCap for cross-platform availability as new markets are added regularly.
Prediction market odds reflect the aggregate opinion of traders who risk real money on outcomes. The price of a share (e.g., 65¢) represents the market's implied probability (65%). Prices move as traders buy and sell based on new information, polls, and analysis.
Buy